Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Mercedes Benz invests in Tamie Mbombo’s company
2016-03-24

Description: Tamie Mbombo Tags: Tamie Mbombo

Tamie Mbombo means business: The Founder and CEO of Sollo Inc, the integrated marketing company endorsed recently by Mercedes Benz South Africa.
Photo:  Hannes Pieterse

A new Mercedes Benz 116 CDI Vito Tourer Pro, a financial injection of R85 000, and 12 months of media coverage by Mercedes Benz is what many Small to Medium Enterprises dream of. For Sollo Inc, that dream became a reality recently after the company won the Boost Your Business 2015 national competition.

In 2012, when Tamie Mbombo was an Investment and Management Banking student at the University of the Free State (UFS), he founded an integrated marketing company, and named it Sollo Inc. The company was launched at the IdeaStart Accelerator, a business incubator for UFS student entrepreneurs.

Four years later, on Friday 18 March 2016, Sollo Inc reached new heights when one of the world’s leading automobile manufacturers presented the Founder and CEO of Solo Inc with a Vito sponsorship at the Bloemfontein Campus.

In addition to serving corporates and the public sector, as part of its social enterprise aspect, Sollo Inc offers certain services free of charge to small businesses. “We capacitate start-ups with organisational skills and financial management as well as marketing education,” explained Mbombo.

Sollo Inc was selected as a winner based on the authentic story behind how Mbombo conducts business. “Mercedes Benz has invested quite a huge sum of money in print and digital media placements as platforms to give exposure to the story behind Sollo Inc,” said Adeesha Ramprith, Client Service Manager at Aqua Online,  Mercedes Benz’s digital marketing agency.

The IdeaStart Accelerator office has commended Mbombo as an example of how young entrepreneurs should keep their ears to the ground, and grab opportunities that might propel their businesses forward. “This is a great milestone for his business, mainly because of the challenges he has faced when it comes to mobility,” said Ayanda Makhanya, Student Entrepreneurship officer at IdeaStart Accelerator.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept